title: Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins.
abstract: Hepatitis C virus (HCV) encodes two viral envelope glycoproteins. E1 contains 4 or 5 N-linked glycosylation sites and E2 contains up to 11, with most of the sites being well conserved, suggesting that they play an essential role in some functions of these proteins. For this study, we used retroviral pseudotyped particles harboring mutated HCV envelope glycoproteins to study these glycans. The mutants were named with an N followed by a number related to the relative position of the potential glycosylation site in each glycoprotein (E1N1 to E1N4 for E1 mutants and E2N1 to E2N11 for E2 mutants). The characterization of these mutants allowed us to define three phenotypes. For the first group (E1N3, E2N3, E2N5, E2N6, E2N7, and E2N9), the infectivities of the mutants were close to that of the wild type. The second group (E1N1, E1N2, E1N4, E2N1, and E2N11) contained mutants that were still infectious but whose infectivities were reduced to <50% that of the wild type. The third group (E2N2, E2N4, E2N8, and E2N10) contained mutants that had almost totally lost infectivity. The absence of infectivity of the E2N8 and E2N10 mutants was due to the lack of incorporation of the E1E2 heterodimer into HCVpp, which was due to misfolding of the heterodimer, as shown by immunoprecipitation with conformation-sensitive antibodies and by a CD81 pull-down assay. The absence of infectivity of the E2N2 and E2N4 mutants indicated that these two glycans are involved in controlling HCV entry. Altogether, the data indicate that some glycans of HCV envelope glycoproteins play a major role in protein folding and others play a role in HCV entry.
authors.affiliation: CNRS-UPR2511, Institut de Biologie de Lille, France.
authors.forename: Anne
authors.initials: A
authors.lastname: Goffard
authors.forename: Nathalie
authors.initials: N
authors.lastname: Callens
authors.forename: Birke
authors.initials: B
authors.lastname: Bartosch
authors.forename: Czeslaw
authors.initials: C
authors.lastname: Wychowski
authors.forename: François-Loïc
authors.initials: FL
authors.lastname: Cosset
authors.forename: Claire
authors.initials: C
authors.lastname: Montpellier
authors.forename: Jean
authors.initials: J
authors.lastname: Dubuisson
mesh_terms: D006528:Carcinoma, Hepatocellular; D045744:Cell Line, Tumor; D015686:Gene Products, env / Q000378:metabolism*; D006031:Glycosylation; D016174:Hepacivirus / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D008113:Liver Neoplasms; D016296:Mutagenesis; D010957:Plasmids; D011134:Polysaccharides / Q000378:metabolism*
chemical_list: D015686:Gene Products, env; D011134:Polysaccharides